BioClinica Expands Operational Capabilities, Opens New European Offices

USA - English

• USA - Deutsch

NEWTOWN, Pa., June 30, 2015 /PRNewswire/ -- BioClinica^®, Inc., the world's leading specialty clinical trial service provider, announced today the opening of new and expanded offices in London and Munich to better serve its growing client base in Europe. The state-of-the-art facilities will offer an array of clinical trial services including medical imaging, site training and support, and eClinical product lines to meet the growing need of European drug and medical device sponsors. BioClinica's clients include top pharmaceutical, biotechnology, and medical device companies as well as CRO partnerships in Europe and across the globe.

"Our new offices will serve as important hubs that enable efficient delivery of tailored resources to our European and Global clients" said John Hubbard, BioClinica's CEO. "Infrastructure investments and the recruitment of local scientific, medical, and regulatory expertise highlights BioClinica's firm commitment to supporting clinical drug development in Europe".

Together, the London and Munich offices offer a combined space of 1,400 square meters to support clinical trial services across key therapeutic areas. With a focus on medical imaging, the European offices will showcase an advanced image analysis center for BioClinica's extensive network of European radiologists and imaging specialists. "Our expansion will provide the resources needed for regional scientific and medical experts to assemble and deliver high quality central review of imaging data for multisite trials in Europe" said David Herron, BioClinica's President of Medical Imaging, Cardiovascular Safety, and Molecular Markers.

BioClinica is holding an open house event for the London office on July 2^nd for clients, sponsors, and partners in which members of the Executive Leadership team and representatives from BioClinica's Medical Imaging and Biomarker, Site network and patient recruitment, and eClinical business segments will be on hand to discuss and demonstrate clinical trial capabilities.

BioClinica is poised to expand its eClinical division in Europe, delivering products and showcasing technologies that facilitate efficient drug development in the region. "Our newly expanded offices provide an interactive environment for training and demonstration of our eClinical technology suite" said Mukhtar Ahmed, President of eClinical Solutions.

The London office is located at 72 Hammersmith Road and the Munich office is located at Landsberger Strasse 290. BioClinica has plans for an Open House at the Munich office later this summer.

For more information on BioClinica's specialized clinical trial services, visit www.bioclinica.com.

About BioClinica, Inc.
BioClinica accelerates the development of new medical therapies by delivering expertise and technologies that enhance clinical research, worldwide. Our industry-leading medical imaging services, cardiac safety, and enterprise eClinical platform bring a new level of quality and efficiency to every phase of clinical development. Our experience spans three decades and includes thousands of studies in all therapeutic areas, from design and management, through submission and post-approval. BioClinica serves more than 400 pharmaceutical, biotechnology, and device companies – including the top 20 – through a network of offices in the U.S., Europe, and Asia.

Logo - http://photos.prnewswire.com/prnh/20130403/PH87647LOGO

SOURCE BioClinica, Inc.

Related Links

http://www.bioclinica.com